A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Abemaciclib
Related studies linked through entity extraction aliases.
A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
ALPINE: Maintenance Letrozole/Abemaciclib
- Status
- RECRUITING
- Phase
- PHASE2
Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
- Status
- RECRUITING
- Phase
- PHASE4
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
- Status
- RECRUITING
- Phase
- PHASE3
Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
- Status
- COMPLETED
- Phase
- PHASE1
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- Status
- RECRUITING
- Phase
- PHASE3
Abemaciclib in Newly Diagnosed Meningioma Patients
- Status
- RECRUITING
- Phase
- PHASE2
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)
- Status
- RECRUITING
- Phase
- PHASE3
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2